Immunotherapy in EGFR mutant non-small cell lung cancer: when, who and how?

مواد مشابهة

• Is the game over for PD-1 inhibitors in EGFR mutant non-small cell lung cancer?
  بواسطة: Velez, Maria A., وآخرون
  منشور في: (2019)
• Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach
  بواسطة: Jassem, Jacek
  منشور في: (2019)
• Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer
  بواسطة: Masago, Katsuhiro, وآخرون
  منشور في: (2019)
• Immunotherapy strategy of EGFR mutant lung cancer
  بواسطة: Yu, Shaorong, وآخرون
  منشور في: (2018)
• Use of adjuvant EGFR tyrosine kinase inhibitors in early stage EGFR-mutant non-small cell lung cancer: is the evidence strong enough?
  بواسطة: Lemmon, Christopher, وآخرون
  منشور في: (2020)